SK bioscience announced that, together with IDT Biologika (IDT) and Australian biotechnology company Vaxxas, it has been ...
As shelf-stable microarray patch (MAP) platforms move through development and clinical work, a ‘packaging first’ mentality is ...
Multiplexing Breakthroughs, Automation, and Bioinformatics Convergence Position Protein Microarrays as a Strategic Imperative ...
Molecular biomarkers can serve as useful diagnostic markers, as prognostic markers for predicting clinical behavior, or as targets for new therapeutic strategies. Application of expression microarray ...
The statistical interaction between genetic susceptibility and lifestyle was significant in the larger cohort and showed ...
The panel ensures compatibility with our previous autosomal Family Finder tests plus all the autosomal transfers we ...
Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 3 of Bionano Symposium 2026, entitled OGM Making its Mark in Constitutional Genetic Disorders. Presentations highlighted how ...
Explore essential statistical strategies for accurate protein quantification and differential expression analysis.
SK bioscience, IDT Biologika, and Vaxxas will collaborate on a next-generation influenza vaccine development initiative.
Vaxxas has been awarded a tender by the European Health and Digital Executive Agency to help develop next-generation ...
LuxScan 10K Microarray Scanner is a compact high performance system for microarray imaging and data analysis of DNA, protein and cell arrays. Its advanced systems for optics, signal processing and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results